Abstract:Background Colorectal carcinoma is one of the most common malignant tumors. Despite advances in therapy, mortality is still very high. The aim of this study was to evaluate the expression of paxillin in the human colon adenocarcinoma cell line SW480 and its role in cell cycle and apoptosis. We also investigated the expression of paxillin in colorectal carcinoma tissues and its relationship to clinicopathological features and survival. Methods Paxillin short hairpin RNA (shRNA) was constructed and transfected into the colon adenocarcinoma cell line SW480. The influence of paxillin shRNA on the cell cycle and cell apoptosis was analyzed by flow cytometry. Immunohistochemistry staining was used to assess the expression of paxillin and its association with the expression of carcinoembryonic antigen (CEA), carbohydrate antigen (CA) 19-9, p53 and Bcl-2 in 102 patients with primary colorectal carcinoma. Western blotting was also used to investigate the expression of paxillin. Medical records were reviewed and a clinicopathological analysis was performed. Results In vitro, the percentage of cells in S phase was (45.23 +/- 1.05)%, (43.53 +/- 1.23)%, and (36.13 +/- 0.57)% in the blank control group, negative control group, and paxillin shRNA group respectively. It was significantly decreased in the paxillin shRNA group (P=0.000). The early apoptosis index of the paxillin shRNA group (17.2 +/- 1.18%) was significantly increased compared to the control shRNA group ((13.17 +/- 1.15)%, P=0.013). Paxillin was positive in 71 (69.6%) patients, and it was found to be overexpressed in tumor tissues compared with normal adjacent tissues. Paxillin positive rate was higher in patients who are less than 50-years old (100.0% vs. 65.6%, P=0.016). Paxillin expression was associated with a high histologic grade of carcinoma (81.4% vs. 61.0%, P=0.031), a high rate of regional lymph node metastasis (22.5% vs. 13.0%, P=0.031), mesenteric artery lymph node metastasis (100.0% vs. 64.8%, P=0.008), distant metastasis (94.1% vs. 64.7%, P=0.016) and a high Tumor Node Metastasis (TNM) stage (94.1%, 73.2%, 60.0%, and 50%, P=0.030). Multivariate analyses revealed that recurrence was associated with the rate of regional lymph node metastasis (P=0.001) and paxillin expression (P=0.024). Multivariate analysis indicated that the overall survival is related to the TNM stage (P=0.000). Conclusions In vitro, paxillin may promote cell proliferation and inhibit apoptosis in SW480 cells. Paxillin may be a potential metastasis predictor, and an independent prognosis factor of recurrence. It may also be related to poor patient outcomes, but was not an independent predictor of survival.

The Roles of Wnt5a, JNK and Paxillin in the Occurrence of Metastasis of Pancreatic Adenocarcinoma

The Role of Paxillin Aberrant Expression in Cancer and Its Potential As a Target for Cancer Therapy

Wnt3a Expression Is Associated with Epithelial-Mesenchymal Transition and Impacts Prognosis of Lung Adenocarcinoma Patients.

Biological Characteristics of Pancreatic Ductal Adenocarcinoma: Initiation to Malignancy, Intracellular to Extracellular.

HMGN5 Promotes Proliferation and Invasion Via the Activation of Wnt/β-catenin Signaling Pathway in Pancreatic Ductal Adenocarcinoma.

Β-Catenin is a Promising Key Factor in the SDF-1/CXCR4 Axis on Metastasis of Pancreatic Cancer

Panx1 Promotes Invasion-Metastasis Cascade in Hepatocellular Carcinoma

Role of non-coding RNAs in tumor progression and metastasis in pancreatic cancer

Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma

Paxillin Knockdown Suppresses Metastasis and Epithelial‑mesenchymal Transition in Colorectal Cancer Via the ERK Signalling Pathway

Aberrant Wnt/β-Catenin Signaling in Pancreatic Adenocarcinoma

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma

Exome sequencing and digital PCR analyses reveal novel mutated genes related to the metastasis of pancreatic ductal adenocarcinoma

Role of paxillin in colorectal carcinoma and its relationship to clinicopathological features.

Expression and Prognostic Significance of CD151, c-Met, and Integrin alpha3/alpha6 in Pancreatic Ductal Adenocarcinoma

Expressions and Clinical Significances of Wnt5a and MMP14 in Gastric Cancer

The JAM-B/c-src/MMP9 Pathway is Associated with Progression and Regulates the Invasion of Pancreatic Cancer.

The Expressions of Hypoxia-Inducible Factor-1Α and Cell Adhesion Molecules in Pancreatic Adenocarcinoma and Their Clinical Significance

S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis

Exploring the Wnt Pathway-Associated LncRNAs and Genes Involved in Pancreatic Carcinogenesis Driven by Tp53 Mutation

Supplementary Table 3 from IGFBP2 Activates the NF-κB Pathway to Drive Epithelial–Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma